Kapplex Overview

  • Founded
  • 2012

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Kapplex General Information


Provider of a point-of-care diagnostic platform intended to diagnose cancer and common infectious diseases. The company's point-of-care diagnostic platform offers a Digital Microfluidic (DMF) platform for use in retail clinics, doctor's offices and care units, enabling clients to simplify and automate traditional sample preparations and analyses on a single, low-cost chip.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • MaRS Centre, South Tower, 101 College Street
  • Suite 200
  • Toronto, Ontario M5G 1L7
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kapplex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 03-May-2016 Completed Startup
2. Grant Completed Startup
1. Early Stage VC Completed Startup
To view Kapplex’s complete valuation and funding history, request access »

Kapplex Executive Team (4)

Name Title Board Seat Contact Info
Aaron Wheeler Ph.D Co-Founder & Head of the Scientific Advisory Board
You’re viewing 1 of 4 executive team members. Get the full list »

Kapplex Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Healthfundr PE/Buyout Minority 000 0000 000000 0
Ontario Centre of Innovation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Sameer Pirani Angel (individual) Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
VentureRadar Corporation Minority 000 0000 000000 0
To view Kapplex’s complete investors history, request access »